Quidel Receives 510(k) Clearance for QuickVue® Influenza A+B Test, Assay Meets FDA’s Class II RIDT Requirements

World News: . []

Quidel Corporation NASDAQ QDEL a provider of rapid diagnostic testing solutions cellular-based virology assays and molecular diagnostic systems, announced today that it has received 510k clearance from the United S tates F...

More news and information about Quidel Corporation

Published By:

Business Wire: 23:45 GMT Tuesday 13th February 2018

Published: .

Search for other references to "quidel" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us